Naphthalene and quinoline sulfonylurea derivatives as ep4...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 209/64 (2006.01) A61K 31/4035 (2006.01) A61K 31/4745 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2681146

The invention is directed to naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutical compositions and methods of use are also included.

L'invention porte sur des dérivés de naphtalène et quinoléine sulfonylurée en tant qu'antagoniste du récepteur EP4, utiles pour le traitement de maladies ou états à médiation par EP4, telles que la douleur aiguë et chronique, l'ostéoarthrite, l'arthrite rhumatoïde et le cancer. L'invention porte également sur des compositions pharmaceutiques et des procédés d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Naphthalene and quinoline sulfonylurea derivatives as ep4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Naphthalene and quinoline sulfonylurea derivatives as ep4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene and quinoline sulfonylurea derivatives as ep4... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1482846

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.